Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

<< Previous

Bullboard Posts

Next >>

Post by yielddudeon Dec 30, 2023 10:53am

187 Views

Post# 35805069

Microbix/Ulisse/Hyris

Microbix partnered with Ulisse back in November. Ulisse merged with Hyris in December. May lead to more business in the future?
https://www.hyris.net/en/solutions/healthcare-diagnostics

Here's an excerpt from the Microbix/Ulisse PR ...
"Moreover, Ulisse’s HPV Assays are validated with the most widely used open platforms and with Hyris bCUBETM, a miniaturized PCR instrument particularly suitable for small-medium laboratories that Ulisse is proposing to clients in conjunction with its assays.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles